FDA could authorize COVID-19 treatment with convalescent plasma as early as next week: WSJ

(Reuters) – The Food and Drug Administration (FDA) could authorize emergency use of antibody-rich blood plasma from recovered COVID-19 patients to treat people infected with the coronavirus as early as next week, the Wall Street Journal reported on Wednesday, citing people familiar with the matter.

(Reporting by Vishwadha Chander in Bengaluru)